The global Corticosteroid Eyedrops Market  experienced significant growth in 2020 and is expected to continue this trend with a steady revenue compound annual growth rate (CAGR) over the forecast period. This growth is driven by several factors, such as the growing prevalence of eye infections and disorders, including macular degeneration and diabetic retinopathy, among an aging global population. Corticosteroid eye drops are primarily used to reduce inflammation, minimize scarring, and prevent glaucoma, cataracts, or blindness. They are also increasingly being used post-surgery as a treatment measure. Inflammatory conditions that cause redness, swelling, or soreness due to injury, infection, or allergies, among other causes, are the main reason for using corticosteroid eye drops.

Corticosteroids are a class of drug that reduce inflammation and immune system activity. Hydrocortisone, loteprednol, prednisolone, and dexamethasone are the most commonly used corticosteroids in eye drops. These corticosteroid eye drops contain antibiotics such as tobramycin, neomycin, and gentamycin, among others, to increase their anti-inflammatory efficiency.

Request a sample Report of Corticosteroid Eyedrops Market https://www.reportsanddata.com/download-free-sample/526

The use of corticosteroid eye drops is primarily indicated for anterior uveitis, which minimizes the inflammatory response and prevents permanent damage to the eye due to glaucoma or cataract. The increasing incidence of high and uncontrollable diabetes has led to a rise in the number of diabetic patients suffering from diabetic retinopathy. Ophthalmic corticosteroids can also treat complex ocular conditions, and these steroids have also been adopted as postoperative therapy to better manage pain and inflammation. They are also used for treating dry eyes, allergic conjunctivitis, non-infectious infiltrative keratitis, and anterior uveitis. The increasing incidence of these conditions is expected to contribute significantly to revenue growth of the market over the forecast period.

However, the prolonged use of corticosteroid eye drops can cause several side effects, such as blurred vision, decreased vision and sensitivity to light, swelling of the eye, and mild discomfort or irritation. Some people may also have allergic reactions to eye drops containing preservatives. Furthermore, corticosteroid eye drops can only be used under prescription, limiting their usage among individuals. These eye drops may also interact with other medications and cause side effects, which is expected to restrain market growth to a certain extent over the forecast period.

The global market for corticosteroid eye drops is segmented by type into cortisone, dexamethasone, tobradex, and others. The dexamethasone segment is expected to account for the largest revenue share over the forecast period. Dexamethasone relieves symptoms of swelling, redness, and itching and is often prescribed to treat eye conditions caused by injury or inflammation. It also reduces irritation and burning in the eyes caused by chemicals, heat, radiation, or foreign bodies in the eyes. As a result, dexamethasone is increasingly prescribed to treat and prevent permanent eye damage, contributing to the revenue growth of the market going forward.

The global market for corticosteroid eye drops is segmented by application into adult and children. The adult segment is expected to register significant revenue growth over the forecast period. Increasing incidence of eye disorders such as age-related macular degeneration, vision impairment, and diabetic retinopathy among the geriatric population is driving demand for corticosteroid eye drops among adults. This is expected to contribute significantly to revenue growth of the segment. Based on regional analysis, North America is expected to account for the largest revenue share in the global market due to the increasing penetration of steroidal medications in the region. Rising

Request a customized copy of the report https://www.reportsanddata.com/request-customization-form/526

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs